The board (the "Board") of directors of CANbridge Pharmaceuticals Inc. (the "Company") hereby announces that Dr. Derek Paul Di Rocco ("Dr. Di Rocco") has tendered his resignation as a non-executive Director and a member of the nomination and corporate governance committee of the Company (the "Nomination and Corporate Governance Committee") with effect from November 23, 2023 (the "Effective Date"), as he would like to devote more time to his personal engagement. Following Dr. Di Rocco's resignation, he has ceased to be a member of the Nomination and Corporate Governance Committee, with effect from the Effective Date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 HKD | -4.41% | +1.56% | -67.17% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-67.17% | 18.49M | |
+18.49% | 78.7B | |
+14.09% | 9.26B | |
-15.14% | 4.92B | |
+45.17% | 4.66B | |
+15.70% | 4.27B | |
+16.71% | 2.44B | |
-26.13% | 2.22B | |
+15.73% | 2.15B | |
-40.52% | 1.89B |
- Stock Market
- Equities
- 1228 Stock
- News CANbridge Pharmaceuticals Inc.
- CANbridge Pharmaceuticals Inc. Announces Resignation of Derek Paul Di Rocco as Non-Executive Director and A Member of the Nomination and Corporate Governance Committee